-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to Q3 2025.
- Tarsus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2025 was $200K, unchanged year-over-year.
- Tarsus Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2025 was $780K.
- Tarsus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2024 was $799K, a 9.62% decline from 2023.
- Tarsus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $884K, a 30% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)